Skip to main content
Erschienen in: Calcified Tissue International 5/2010

01.05.2010

Autocrine/Paracrine Action of Vitamin D on FGF23 Expression in Cultured Rat Osteoblasts

verfasst von: Wen-Jing Tang, Li-Fang Wang, Xiao-Ya Xu, Yi Zhou, Wei-Fang Jin, Hong-Fu Wang, Jianjun Gao

Erschienen in: Calcified Tissue International | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

To explore the local mechanisms of fibroblast growth factor (FGF) 23 regulations, we examined the FGF23 expression patterns in an osteoblast culture model. The characteristics of cultured rat calvaria osteoblasts in half-confluence, confluence, osteoid deposition, and osteoid mineralization stages might reflect the proliferation, differentiation, maturation, and matrix mineralization stages, respectively. Compared with proliferating cells in half-confluence, FGF23 expression was upregulated by 7.5-fold at the mRNA level and 126% at the protein level in confluent differentiated cells as determined by real-time RT-PCR and Western blot analysis. Interestingly, mRNA levels of CYP27B1 (the gene coding for 1α-hydroxylase enzyme which catalyses the conversion of 1α,25-dihydroxyvitamin D, 1α,25[OH]2D, from its inactive form, 25-hydroxycholecalciferol, 25[OH]D) and CYP24A (the gene coding for 24-hydroxylase, a target gene of 1α,25[OH]2D) were significantly increased by twofold and 34-fold, respectively, in differentiated osteoblasts compared with proliferating cells. We next examined if the local production of 1α,25(OH)2D might contribute to the FGF23 upregulation. We cultured osteoblasts in serum-free medium with or without 25-(OH)D (the substrate of 1α-hydroxylase). FGF23 mRNA levels were increased in proliferating cells (16-fold) and in differentiated cells (28-fold) by the physiological dose of 25-(OH)D3 treatment. CYP27B1 was slightly but significantly upregulated and CYP24A was increased by 1,700-fold and 800-fold, respectively, in transcriptional levels. Because FGF23 was upregulated in confluent osteoblasts regardless of the presence or absence of 25-(OH)D in serum-free medium, we further examined the possible impact of cell communication on FGF23 expression. We treated osteoblasts with carbenoxolone, a gap junction Cx43 blocker in serum-free medium. The FGF23 mRNA level was reduced by 50% in confluent differentiated cells and slightly but not significantly reduced in half-confluent cells by carbenoxolone treatments. The results suggested that upregulation of FGF23 in differentiated osteoblast appeared to be due to increased autocrine/paracrine action of osteoblast-derived 1α,25(OH)2D and increased cell communication, which were identified in cultured rat calvaria osteoblasts. These results indicate that FGF23 expression was stimulated not only by circulating calcitriol but also by locally produced 1α,25(OH)2D. The local mechanisms of FGF23 expression remain to be characterized.
Literatur
1.
Zurück zum Zitat Shimada T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500–6505CrossRefPubMed Shimada T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500–6505CrossRefPubMed
2.
Zurück zum Zitat Consortium ADHR (2000) Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet 26:345–348CrossRef Consortium ADHR (2000) Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet 26:345–348CrossRef
3.
Zurück zum Zitat Quarles LD (2003) Evidence for a bone–kidney axis regulating phosphate homeostasis. J Clin Invest 112:642–646PubMed Quarles LD (2003) Evidence for a bone–kidney axis regulating phosphate homeostasis. J Clin Invest 112:642–646PubMed
4.
Zurück zum Zitat Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656–1663CrossRefPubMed Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656–1663CrossRefPubMed
5.
Zurück zum Zitat White KE, Econs MJ (2008) Fibroblast growth factor-23. In: Rosen CJ (ed) Primer on the metabolic bone disease and disorders of mineral metabolism, 7th edn. American Society for Bone and Mineral Research, Washington DC, pp 112–116 White KE, Econs MJ (2008) Fibroblast growth factor-23. In: Rosen CJ (ed) Primer on the metabolic bone disease and disorders of mineral metabolism, 7th edn. American Society for Bone and Mineral Research, Washington DC, pp 112–116
6.
Zurück zum Zitat Liu S, Tang W, Zhou J, Stubbs JR, Luo Q, Pi M, Quarles LD (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17:1305–1315CrossRefPubMed Liu S, Tang W, Zhou J, Stubbs JR, Luo Q, Pi M, Quarles LD (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17:1305–1315CrossRefPubMed
7.
Zurück zum Zitat Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro OM, Mohammadi M, Sirkis R, Naveh-Many T, Silver J (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117:4003–4008PubMed Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro OM, Mohammadi M, Sirkis R, Naveh-Many T, Silver J (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117:4003–4008PubMed
8.
Zurück zum Zitat Krajisnik T, Bjorklund P, Marsell R, Ljunggren O, Akerstrom G, Jonsson KB, Westin G, Larsson TE (2007) Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195:125–131CrossRefPubMed Krajisnik T, Bjorklund P, Marsell R, Ljunggren O, Akerstrom G, Jonsson KB, Westin G, Larsson TE (2007) Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195:125–131CrossRefPubMed
9.
Zurück zum Zitat Yoshiko Y, Wang H, Minamizaki T, Ijuin C, Yamamoto R, Suemune S, Kozai K, Tanne K, Aubin JE, Maedaet N (2007) Mineralized tissue cells are a principal source of FGF23. Bone 40:1565–1573CrossRefPubMed Yoshiko Y, Wang H, Minamizaki T, Ijuin C, Yamamoto R, Suemune S, Kozai K, Tanne K, Aubin JE, Maedaet N (2007) Mineralized tissue cells are a principal source of FGF23. Bone 40:1565–1573CrossRefPubMed
10.
Zurück zum Zitat Martin A, Quarles LD (2009) The actors in phosphate metabolism and bone mineral homeostasis: meeting report from the 31st annual meeting of the American Society for Bone and Mineral Research. IBMS BoneKEy 6:455–458CrossRef Martin A, Quarles LD (2009) The actors in phosphate metabolism and bone mineral homeostasis: meeting report from the 31st annual meeting of the American Society for Bone and Mineral Research. IBMS BoneKEy 6:455–458CrossRef
11.
Zurück zum Zitat Bellows CG, Aubin JE, Heersche JN, Antosz ME (1986) Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 38:143–154CrossRefPubMed Bellows CG, Aubin JE, Heersche JN, Antosz ME (1986) Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 38:143–154CrossRefPubMed
12.
Zurück zum Zitat Aubin JE, Lain JB, Stein GS (2006) Bone formation: maturation and functional activities of osteoblast lineage cells. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 6th edn. American Society for Bone and Mineral Research, Washington DC, pp 20–29 Aubin JE, Lain JB, Stein GS (2006) Bone formation: maturation and functional activities of osteoblast lineage cells. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 6th edn. American Society for Bone and Mineral Research, Washington DC, pp 20–29
13.
Zurück zum Zitat Wang H-F, Jin W-F, Gao J-J (2001) Osteoblast culture techniques in vitro. In: Wang H-F (ed) An atlas of bone cells & cell culture techniques. Shanghai Scientific & Technical Publishers, Shanghai, pp 54–55 Wang H-F, Jin W-F, Gao J-J (2001) Osteoblast culture techniques in vitro. In: Wang H-F (ed) An atlas of bone cells & cell culture techniques. Shanghai Scientific & Technical Publishers, Shanghai, pp 54–55
14.
Zurück zum Zitat Wang H-F, Jin W-F, Gao J-J, Sheng H (2008) Osteoblast culture and pharmacological evaluation in vitro. In: Leung KS, Qin YX, Cheung WH, Qin L (eds) A practical manual for musculoskeletal research. World Scientific, Singapore, pp 99–112CrossRef Wang H-F, Jin W-F, Gao J-J, Sheng H (2008) Osteoblast culture and pharmacological evaluation in vitro. In: Leung KS, Qin YX, Cheung WH, Qin L (eds) A practical manual for musculoskeletal research. World Scientific, Singapore, pp 99–112CrossRef
15.
Zurück zum Zitat Gao J, Tiwari-Pandey R, Samadfam R, Yang Y, Miao D, Karaplis AC, Sairam MR, Goltzman D (2007) Altered ovarian function affects skeletal homeostasis independent of the action of follicle-stimulating hormone (FSH). Endocrinology 148:2613–2621CrossRefPubMed Gao J, Tiwari-Pandey R, Samadfam R, Yang Y, Miao D, Karaplis AC, Sairam MR, Goltzman D (2007) Altered ovarian function affects skeletal homeostasis independent of the action of follicle-stimulating hormone (FSH). Endocrinology 148:2613–2621CrossRefPubMed
16.
Zurück zum Zitat Anderson PH, O’Loughlin PD, Maya BK, Morris HA (2005) Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels. Bone 36:654–662CrossRefPubMed Anderson PH, O’Loughlin PD, Maya BK, Morris HA (2005) Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels. Bone 36:654–662CrossRefPubMed
17.
Zurück zum Zitat Howard GA, Turner RT, Sherrard DJ, Baylink DJ (1981) Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J Biol Chem 256:7738–7740PubMed Howard GA, Turner RT, Sherrard DJ, Baylink DJ (1981) Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J Biol Chem 256:7738–7740PubMed
18.
Zurück zum Zitat Ichikawa F, Sato K, Nanjo M, Nishii Y, Shinki T, Takahashi N, Suda T (1995) Mouse primary osteoblasts express vitamin D3 25-hydroxylase mRNA and convert 1α-hydroxyvitamin D3 into 1α,25-dihydroxyvitamin D3. Bone 16:129–135CrossRefPubMed Ichikawa F, Sato K, Nanjo M, Nishii Y, Shinki T, Takahashi N, Suda T (1995) Mouse primary osteoblasts express vitamin D3 25-hydroxylase mRNA and convert 1α-hydroxyvitamin D3 into 1α,25-dihydroxyvitamin D3. Bone 16:129–135CrossRefPubMed
19.
Zurück zum Zitat van Driel M, Koedam M, Buurman CJ, Hewison M, Chiba H, Uitterlinden AG, Pols HA, van Leeuwen JP (2006) Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. FASEB J 20:2417–2419CrossRefPubMed van Driel M, Koedam M, Buurman CJ, Hewison M, Chiba H, Uitterlinden AG, Pols HA, van Leeuwen JP (2006) Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. FASEB J 20:2417–2419CrossRefPubMed
20.
Zurück zum Zitat Kemmis CM, Salvador SM, Smith KM, Welsh J (2006) Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D3, the major circulating form of vitamin D3. J Nutr 136:887–892PubMed Kemmis CM, Salvador SM, Smith KM, Welsh J (2006) Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D3, the major circulating form of vitamin D3. J Nutr 136:887–892PubMed
21.
Zurück zum Zitat Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino ACW, O’Loughlin PD, Morris HA (2007) Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D3. Bone 40:1517–1528CrossRefPubMed Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino ACW, O’Loughlin PD, Morris HA (2007) Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D3. Bone 40:1517–1528CrossRefPubMed
22.
Zurück zum Zitat Anderson PH, Atkins GJ, Findlay DM, Oloughlin PD, Welldon K, Vincent C, Morris HA (2007) RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)2D3 synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells. J Steroid Biochem Mol Biol 103:601–605CrossRefPubMed Anderson PH, Atkins GJ, Findlay DM, Oloughlin PD, Welldon K, Vincent C, Morris HA (2007) RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)2D3 synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells. J Steroid Biochem Mol Biol 103:601–605CrossRefPubMed
23.
Zurück zum Zitat Anderson PH, Sawyer RK, Moore AJ, May BK, O’Loughlin PD, Morris HA (2008) Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model. J Bone Miner Res 23:1789–1797CrossRefPubMed Anderson PH, Sawyer RK, Moore AJ, May BK, O’Loughlin PD, Morris HA (2008) Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model. J Bone Miner Res 23:1789–1797CrossRefPubMed
24.
Zurück zum Zitat Lecanda F, Warlow PM, Sheikh S, Furlan F, Steinberg TH, Civitelli R (2000) Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J Cell Biol 151:931–944CrossRefPubMed Lecanda F, Warlow PM, Sheikh S, Furlan F, Steinberg TH, Civitelli R (2000) Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J Cell Biol 151:931–944CrossRefPubMed
25.
Zurück zum Zitat Chung DJ, Castro CH, Watkins M, Stains JP, Chung MY, Szejnfeld VL, Willecke K, Theis M, Civitelli R (2006) Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43. J Cell Sci 119:4187–4198CrossRefPubMed Chung DJ, Castro CH, Watkins M, Stains JP, Chung MY, Szejnfeld VL, Willecke K, Theis M, Civitelli R (2006) Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43. J Cell Sci 119:4187–4198CrossRefPubMed
26.
Zurück zum Zitat McLachlan E, Plante I, Shao Q, Tong D, Kidder GM, Bernier SM, Laird DW (2008) ODDD-linked Cx43 mutants reduce endogenous Cx43 expression and function in osteoblasts and inhibit late stage differentiation. J Bone Miner Res 23:928–938CrossRefPubMed McLachlan E, Plante I, Shao Q, Tong D, Kidder GM, Bernier SM, Laird DW (2008) ODDD-linked Cx43 mutants reduce endogenous Cx43 expression and function in osteoblasts and inhibit late stage differentiation. J Bone Miner Res 23:928–938CrossRefPubMed
27.
Zurück zum Zitat Saez JCT, Retamal MA, Basilio D, Bukauskas FF, Bennett MVL (2005) Connexin-based gap junction hemichannels: gating mechanisms. Biochim Biophys Acta 1711:215–224CrossRefPubMed Saez JCT, Retamal MA, Basilio D, Bukauskas FF, Bennett MVL (2005) Connexin-based gap junction hemichannels: gating mechanisms. Biochim Biophys Acta 1711:215–224CrossRefPubMed
28.
Zurück zum Zitat Masuyama R, Stockmans I, Torrekens S, Looveren RV, Maes C, Carmelie P, Bouillon R, Carmeliet G (2006) Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 116:3150–3159CrossRefPubMed Masuyama R, Stockmans I, Torrekens S, Looveren RV, Maes C, Carmelie P, Bouillon R, Carmeliet G (2006) Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 116:3150–3159CrossRefPubMed
Metadaten
Titel
Autocrine/Paracrine Action of Vitamin D on FGF23 Expression in Cultured Rat Osteoblasts
verfasst von
Wen-Jing Tang
Li-Fang Wang
Xiao-Ya Xu
Yi Zhou
Wei-Fang Jin
Hong-Fu Wang
Jianjun Gao
Publikationsdatum
01.05.2010
Verlag
Springer-Verlag
Erschienen in
Calcified Tissue International / Ausgabe 5/2010
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-010-9355-2

Weitere Artikel der Ausgabe 5/2010

Calcified Tissue International 5/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Innere Medizin

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Krebspatienten impfen: Was? Wen? Und wann nicht?

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Nierenultraschall: Tipps vom Profi

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

„KI sieht, was wir nicht sehen“

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.